MIOSTAT

This brand name is authorized in United States. It is also authorized in Canada, Ecuador, Estonia, France, Hong Kong SAR China, Netherlands, New Zealand, Poland, Singapore, Turkey.

Active ingredients

The drug MIOSTAT contains one active pharmaceutical ingredient (API):

1	Carbachol UNII 8Y164V895Y - CARBACHOL
	Carbachol is a potent cholinergic (parasympathomimetic) agent which produces constriction of the iris and ciliary body resulting in reduction in intraocular pressure (IOP).
	Read more about Carbachol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MIOSTAT Solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01EB02	Carbachol	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EB Parasympathomimetics
Discover more medicines within S01EB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00042544
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	16.108-2-04-02
EE	Ravimiamet	1111789, 1730348
FR	Base de données publique des médicaments	67713498
HK	Department of Health Drug Office	24136
NL	Z-Index G-Standaard	13930656
NL	Z-Index G-Standaard, PRK	27839
NZ	Medicines and Medical Devices Safety Authority	2405
PL	Rejestru Produktów Leczniczych	100044030
SG	Health Sciences Authority	04572P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699760610189, 8699760610196
US	FDA, National Drug Code	0065-0023